Back to search
FDAFDA · Food and drugs·Recall number D-280-2013

Comprehensive injection #4 - SS varied injectable Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

Published May 1, 2013 · Recall initiated: April 17, 2013

Summary

FDA records drug Class II recall D-280-2013, published May 1, 2013 and initiated April 17, 2013. Recalling firm: Axium Healthcare Pharmacy dba Balanced Solutions Compounding; Status: Terminated; Reported quantity: 10 vials (30 mL each); Lot: All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Axium Healthcare Pharmacy dba Balanced Solutions Compounding
Distributor
CO, GA, MI, and Puerto Rico
Lot
All Lots
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Comprehensive injection #4 - SS varied injectable Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746 recalled?

Yes. FDA published recall D-280-2013 on May 1, 2013. Reported hazard: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit